Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Warshawsky

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Journal of Biological Chemistry|April 18, 1997
Differential functions of triplicated repeats suggest two independent roles for the receptor-associated protein as a molecular chaperoneL M Obermoeller, I Warshawsky, M R Wardell, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1991
Identification, cloning, and expression of a cytosolic megakaryocyte protein-tyrosine-phosphatase with sequence homology to cytoskeletal protein 4.1M X Gu, J D York, I Warshawsky, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 21, 2013
Donor T-cell chimerism and early post-transplant cytomegalovirus viremia in patients treated with myeloablative allogeneic hematopoietic stem cell transplantS Taimur, M Askar, R Sobecks, et al.
The Journal of Biological Chemistry|October 6, 1995
Analysis of ligand binding to the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that lipoprotein lipase and the carboxyl-terminal domain of the receptor-associated protein bind to the same siteM S Nielsen, A Nykjaer, I Warshawsky, et al.
The Journal of Clinical Investigation|April 1, 1995
The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivoI Warshawsky, G Bu, A Mast, et al.
The Biochemical Journal|November 14, 1997
Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitorA E Mast, D A Higuchi, Z F Huang, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Journal of Biological Chemistry|April 18, 1997
Differential functions of triplicated repeats suggest two independent roles for the receptor-associated protein as a molecular chaperoneL M Obermoeller, I Warshawsky, M R Wardell, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1991
Identification, cloning, and expression of a cytosolic megakaryocyte protein-tyrosine-phosphatase with sequence homology to cytoskeletal protein 4.1M X Gu, J D York, I Warshawsky, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 21, 2013
Donor T-cell chimerism and early post-transplant cytomegalovirus viremia in patients treated with myeloablative allogeneic hematopoietic stem cell transplantS Taimur, M Askar, R Sobecks, et al.
The Journal of Biological Chemistry|October 6, 1995
Analysis of ligand binding to the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that lipoprotein lipase and the carboxyl-terminal domain of the receptor-associated protein bind to the same siteM S Nielsen, A Nykjaer, I Warshawsky, et al.
The Journal of Clinical Investigation|April 1, 1995
The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivoI Warshawsky, G Bu, A Mast, et al.
The Biochemical Journal|November 14, 1997
Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitorA E Mast, D A Higuchi, Z F Huang, et al.
Pageof 2